SCHEMBL6169811

SCHEMBL6169811

CCC(=O)Nc1ncc(Br)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNK O75909 1/20 0.46
CDK12 Q9NYV4 1/20 0.46
GAA P10253 2/20 0.46
RAB9A P51151 3/20 0.44
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43
ADORA3 P0DMS8 8/20 0.42
ADORA2A P29274 5/20 0.42
ADORA2B P29275 4/20 0.42
ADORA1 P30542 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
EGFR P00533 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
HPGD P15428 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31241012 0.85 RAB9A (0.53) RAB9ALMNAADORA3ADORA2AADORA1
SCHEMBL19150987 0.82 LMNA (0.44) GAARAB9ALMNAHTTADORA3
SCHEMBL19151157 0.82 ADORA3 (0.50) RAB9ALMNAHTTADORA3ADORA2A
SCHEMBL31241118 0.82 RAB9A (0.66) RAB9ALMNAADORA1SMN1; SMN2KMT2A
SCHEMBL31241073 0.81 RAB9A (0.65) RAB9ALMNAADORA1SMN1; SMN2KMT2A
SCHEMBL25950912 0.81 MAPT (0.49) RAB9ALMNAHTTADORA3ADORA2A
SCHEMBL25948055 0.81 ADORA3 (0.45) RAB9ALMNAHTTADORA3ADORA2A
SCHEMBL7934008 0.81 TSHR (0.39) RAB9ALMNAHTTKMT2AALDH1A1
SCHEMBL2275255 0.78 MEN1 (0.43) RAB9ALMNAHTTADORA3ADORA1
SCHEMBL4409751 0.78 LMNA (0.68) GAARAB9ALMNAHTTADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118812505-A PI5P4K gamma inhibitor compound, pharmaceutical composition, and preparation method and application thereof 贵州医科大学 2024-10-22 CN disclosed
EP-0794774-B1 4,4-(DISUBSTITUTED)CYCLOHEXAN-1-OLS MONOMERS AND RELATED COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2005-10-12 EP disclosed
CN-1090020-C 4, 4- (disubstituted) cyclohexan-1-ol monomers and related compounds SMITHKLINE BEECHAM CORP (US) 2002-09-04 CN disclosed
US-6037367-A Substituted-pent-4-ynoic acids SMITHKLINE BEECHAM CORPORATION (US) 2000-03-14 US disclosed
US-5891883-A 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds SMITHKLINE BEECHAM CORPORATION (US) 1999-04-06 US disclosed
EP-0827495-A4 SUBSTITUTED-PENT-4-YNOIC ACIDS SMITHKLINE BEECHAM CORP (US) 1998-11-04 EP disclosed
EP-0794774-A4 4,4-(DISUBSTITUTED)CYCLOHEXAN-1-OLS MONOMERS AND RELATED COMPOUNDS SMITHKLINE BEECHAM CORP (US) 1998-04-29 EP disclosed
EP-0827495-A1 SUBSTITUTED-PENT-4-YNOIC ACIDS SMITHKLINE BEECHAM CORPORATION (US) 1998-03-11 EP disclosed
CN-1175210-A 4, 4 -(disubstituted) cyclohexan -1 -ols and related compounds SMITHKLINE BEECHAM CORP (US) 1998-03-04 CN disclosed
EP-0794774-A1 4,4-(DISUBSTITUTED)CYCLOHEXAN-1-OLS MONOMERS AND RELATED COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1997-09-17 EP disclosed
WO-1997003945-A1 SUBSTITUTED-PENT-4-YNOIC ACIDS SMITHKLINE BEECHAM CORPORATION (US) 1997-02-06 WO disclosed
WO-1996019988-A1 4,4-(DISUBSTITUTED)CYCLOHEXAN-1-OLS MONOMERS AND RELATED COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1996-07-04 WO disclosed